arrow
Back
C

Christopher T. Ritchlin

University of Rochester

76H-index
545Paper Count
2.6WCitation Count
Published Papers 185
Publication Date
Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis
err2026-05-05
err0
errOAAI
errChristopher T. Ritchlin; Laura C. Coates; Philip J. Mease; Désirée van der Heijde; Proton Rahman
errShare
errSave
Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial
err2025-10-06
err0
errOAAI
errIain B. McInnes; Laura C. Coates; Philip J. Mease; Alexis Ogdie; Arthur Kavanaugh; Lihi Eder; Georg Schett; Alan Kivitz; Dennis McGonagle; Nuala Brennan; Alex Godwood; Eva Cullen; Kristian Reich; Christopher T. Ritchlin; Joseph F. Merola
errShare
errSave
Relationship of radiographic progression status to low disease activity in patients with PsA receiving secukinumab treatment for 2 years
err2025-10-01
err0
PREAI
errMease, Philip J.; Coates, Laura C.; Gaillez, Corine; Shew, Alexis; Bao, Weibin; Ritchlin, Christopher T.
errShare
errSave
Inhibition of Structural Damage Progression With Guselkumab in Participants With Active Psoriatic Arthritis: Results Through Week 24 of the Phase 3b, Randomized, Double-Blind, Placebo-Controlled APEX Study
err2025-10-01
err0
PREAI
errMease, Philip J.; Ritchlin, Christopher T.; Coates, Laura C.; Kollmeier, Alexa P.; Zhou, Bei; Jiang, Yusang; Bensley, Karen; Im, Koeun; Batra, Rattandeep; Chakravarty, Soumya; Rahman, Proton; van der Heijde, Desiree
errShare
errSave
Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study
err2025-07-21
err0
errOAAI
errChristopher T. Ritchlin; Ennio Lubrano; Maria Sole Chimenti; Evan Leibowitz; Mohamed Sharaf; Emmanouil Rampakakis; Francois Nantel; Frederic Lavie; Atul Deodhar
errShare
errSave
New Insights into the Pathogenesis of Psoriatic Arthritis
err2025-06-11
err0
PREAI
errMaria de la Luz Garcia-Hernandez; Christopher T. Ritchlin; Diamond R. Guy; Mihir Wechalekar
errShare
errSave
Psoriatic arthritis: diagnosis, pathogenesis, and emerging therapies
err2025-06-10
err0
PREAI
errIannis E. Adamopoulos; Xenofon Baraliakos; Christopher Ritchlin
errShare
errSave
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab
err2025-06-06
err0
errOAAI
errJan Brandt-Jürgens; Martin Rudwaleit; Frank Behrens; Christopher Ritchlin; Daniel Peterlik; Erhard Quebe-Fehling; Atul Deodhar
errShare
errSave
Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
err2025-05-10
err0
errOAAI
errPhilip J. Mease; Joseph F. Merola; Yoshiya Tanaka; Laure Gossec; Iain B. McInnes; Christopher T. Ritchlin; Robert B. M. Landewé; Akihiko Asahina; Barbara Ink; Andrea Heinrichs; Rajan Bajracharya; Vishvesh Shende; Jason Coarse; Laura C. Coates
errShare
errSave
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies (vol 11, pg 1363, 2024)
err2025-05-05
err0
errOAAI
errPhilip J. Mease; Joseph F. Merola; Yoshiya Tanaka; Laure Gossec; Iain B. McInnes; Christopher T. Ritchlin; Robert B. M. Landewé; Akihiko Asahina; Barbara Ink; Andrea Heinrichs; Rajan Bajracharya; Vishvesh Shende; Jason Coarse; Laura C. Coates
errShare
errSave
Bimekizumab maintained efficacy responses in patients with active psoriatic arthritis: up to 2-year results from two Phase 3 studies
err2025-04-28
err0
PREAI
errWalsh, Jessica A.; Merola, Joseph F.; Ritchlin, Christopher T.; Tanaka, Yoshiya; Favalli, Ennio G.; Mcgonagle, Dennis; Thaci, Diamant; Ink, Barbara; Bajracharya, Rajan; Coarse, Jason; Tillett, William
errShare
errSave
Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling
err2025-03-12
err1
errOAAI
errSachen, Kacey L.; Hammaker, Deepa; Sarabia, Indra; Stoveken, Brian; Hartman, John; Leppard, Kristin L.; Manieri, Nicholas A.; Bao, Phuc; Greving, Carrie; Lacy, Eilyn R.; Duprie, Matthew; Wertheimer, Joshua; Deming, Janise D.; Brown, Joseph; Hart, Amy; Li, He (Hurley); Freeman, Tom C.; Keyes, Brice; Kohler, Kristen; White, Ian; Karpowich, Nathan; Steele, Ruth; Elloso, M. Merle; Fakharzadeh, Steven; Goyal, Kavitha; Lavie, Frederic; Abreu, Maria T.; Allez, Matthieu; Atreya, Raja; Bissonnette, Robert; Eyerich, Kilian; Krueger, James G.; Mcgonagle, Dennis; Mcinnes, Iain B.; Ritchlin, Christopher; Fourie, Anne M.
errShare
errSave
Tofacitinib Efficacy/Safety in Patients with Ankylosing Spondylitis by Baseline Body Mass Index: A Post Hoc Analysis of Phase 2/3 Trials
err2024-12-05
err0
errOAAI
errNorton, Hillary; Sliwinska-Stanczyk, Paula; Hala, Tomas; El-Zorkany, Bassel; Stockert, Lori; Mundayat, Rajiv; Wang, Lisy; Ritchlin, Christopher T.
errShare
errSave
Are There Disease Endotypes in Axial Spondyloarthritis and How Would We Define Them?
err2024-10-24
err1
errOAAI
errDeane, Kevin D.; Donlin, Laura T.; Ritchlin, Christopher T.; Kuhn, Kristine A.
errShare
errSave
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease
err2024-08-01
err0
PREAI
errStolnicki, Daniela Kampel; Coates, Laura C.; Gollins, Charlotte E.; Koppikar, Sahil; Perez-Chada, Lourdes M.; Puig, Luis; Ogdie, Alexis; Deodhar, Atul; Ritchlin, Christopher; Hwang, Samuel T.; Goldenstein-Schainberg, Claudia
errShare
errSave
GRAPPA 2023 Collaborative Research Network Meeting
err2024-07-15
err0
PREAI
errChandran, Vinod; Gladman, Dafna D.; Mease, Philip J.; Eder, Lihi; Pennington, Stephen R.; Fitzgerald, Oliver; Ritchlin, Christopher; Webster, Dan E.; de Vlam, Kurt; Liao, Wilson
errShare
errSave
Psoriatic arthritis subtypes are phenocopied in humanized mice
err2024-07-02
err0
errOAAI
errRitchlin, Christopher T.; Rangel-Moreno, Javier; Martino, Delaney; Isett, Brian; Paine, Ananta; Bhattacharya, Soumyaroop; Fox, Jeffrey; Meyer, Ernest M.; Bao, Riyue; Bruno, Tullia; Tausk, Francisco; Garcia-Hernandez, Maria de la Luz
errShare
errSave
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses
err2024-07-01
err0
errOAAI
errFitzgerald, Oliver; Gladman, Dafna D.; Mease, Philip J.; Ritchlin, Christopher; Smolen, Josef S.; Gao, Lu; Hu, Yanhua; Nowak, Miroslawa; Banerjee, Subhashis; Catlett, Ian
errShare
errSave
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
err2024-06-01
err0
PREAI
errChat, Vipawee S.; Ellebrecht, Christoph T.; Kingston, Paige; Gondo, George; Bell, Stacie; Cordoro, Kelly M.; Desai, Seemal R.; Duffin, Kristina C.; Feldman, Steven R.; Garg, Amit; Gelfand, Joel M.; Gladman, Dafna; Green, Lawrence J.; Gudjonsson, Johann; Han, George; Hawkes, Jason E.; Kircik, Leon; Koo, John; Langley, Richard; Lebwohl, Mark; Lewitt, G. Michael; Liao, Wilson; Martin, George; Orbai, Ana-Maria; Reddy, Soumya M.; Richardson, Veronica; Ritchlin, Christopher T.; Schwartzman, Sergio; Siegel, Evan L.; Van Voorhees, Abby S.; Wallace, Elizabeth B.; Weinberg, Jeffrey M.; Winthrop, Kevin L.; Yamauchi, Paul; Armstrong, April W.
errShare
errSave